Equities

Varex Imaging Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Varex Imaging Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)13.52
  • Today's Change0.14 / 1.05%
  • Shares traded86.00
  • 1 Year change-0.66%
  • Beta0.8792
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Varex Imaging Corporation is a designer and manufacturer of X-ray imaging components, which include X-ray tubes, digital detectors and other image processing solutions that are key components of X-ray imaging systems. The Company’s segments include Medical and Industrial. Its Medical segment designs, manufactures, sells and services X-ray imaging components, including X-ray tubes, flat panel and photon-counting detectors and accessories, high-voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and coolers. Its Industrial segment designs, develops, manufactures, sells, and services X-ray imaging products for use in a number of applications, including security applications for cargo screening at ports and borders, baggage screening at airports, and nondestructive testing, irradiation, and inspection applications used in a number of other verticals.

  • Revenue in USD (TTM)854.40m
  • Net income in USD-67.70m
  • Incorporated2016
  • Employees2.40k
  • Location
    Varex Imaging Corp1678 S Pioneer RdSALT LAKE CITY 84104-4205United StatesUSA
  • Phone+1 (801) 972-5000
  • Fax+1 (302) 636-5454
  • Websitehttps://www.vareximaging.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AngioDynamics, Inc.307.31m-27.71m452.15m675.00--2.59--1.47-0.6731-0.67317.474.241.102.127.02455,268.20-9.87-13.69-13.83-16.1954.5852.46-9.02-21.321.33--0.0329---3.762.0681.56---10.06--
Neuropace Inc94.86m-23.99m497.88m209.00--27.05--5.25-0.7535-0.75352.980.55640.93211.467.16515,565.20-23.57-35.71-28.36-44.3476.7773.39-25.28-60.453.94-3.580.7603--22.1416.6717.64---8.15--
Mesa Laboratories Inc247.54m3.73m500.49m730.00140.002.6817.412.020.64710.647144.8133.790.56783.406.28339,097.300.8564-8.811.13-9.7162.4061.981.51-25.151.451.620.4709--11.4715.4199.22--24.600.00
Pacific Biosciences of California Inc160.01m-546.38m516.26m575.00--96.52--3.23-1.84-1.840.53350.01770.15651.965.08---53.45-22.47-59.23-24.4033.9733.11-341.47-214.452.44-19.720.9918--3.8915.19-76.34------
Anteris Technologies Global Corp2.14m-84.32m523.69m136.00--55.68--244.82-2.34-2.340.05940.10250.10651.5311.8815,728.75-420.16---1,527.00--67.94---3,945.70--0.8032--0.046---1.16---65.77------
Orthofix Medical Inc818.06m-119.12m529.84m1.62k--1.19--0.6477-3.04-3.0420.8211.200.96221.376.40506,224.00-14.01-10.81-17.28-13.3468.2770.31-14.56-11.571.38-1.350.2837--7.0811.6916.78--8.75--
Cytek Biosciences Inc196.83m-12.82m542.15m692.00--1.43--2.75-0.1011-0.10111.542.960.39921.863.60303,746.90-2.600.3407-3.020.381153.4658.12-6.510.86784.48--0.0213--3.8528.2050.44--30.83--
Varex Imaging Corp854.40m-67.70m566.49m2.40k--1.19--0.663-1.63-1.6319.3411.380.70321.856.00356,000.00-5.55-0.3327-6.45-0.395534.1533.16-7.89-0.46611.872.220.4321--4.142.73-47.38---0.5159--
Tactile Systems Technology Inc311.51m18.17m590.78m1.04k34.052.8823.721.900.77680.776813.289.181.148.388.07300,398.306.641.297.721.5549.8749.125.831.263.20--0.000.006.769.11-40.529.10-15.97--
Embecta Corp1.08bn139.50m602.27m1.85k4.30--3.330.55782.372.3718.31-10.350.97572.276.35583,621.6012.6116.6916.6022.6563.1766.7412.9215.711.873.181.7913.07-3.80-0.103321.84-25.93-26.03--
Beta Bionics Inc88.57m-77.84m613.70m404.00--2.08--6.93-2.07-2.072.216.700.41492.548.16304,364.30-36.46---40.57--54.51---87.89--9.83--0.00--442.93---24.17------
Alpha Tau Medical Ltd0.00-39.97m614.75m125.00--7.92-----0.5212-0.52120.000.90990.00----0.00-40.90-34.28-44.43-36.47------------0.0735-------8.89--11.60--
SI-Bone Inc193.58m-21.76m665.19m349.00--3.85--3.44-0.5113-0.51134.553.980.83931.297.53554,664.80-9.43-24.17-10.61-26.8779.6282.72-11.24-40.936.62--0.1711--20.3719.9628.67--33.83--
Bioventus Inc563.83m7.82m684.45m950.0073.624.1211.931.210.11230.11238.392.010.76661.954.47606,267.801.31-6.291.89-8.4967.7667.401.71-12.071.141.730.616--11.8911.0065.33---15.55--
Data as of Feb 13 2026. Currency figures normalised to Varex Imaging Corp's reporting currency: US Dollar USD

Institutional shareholders

50.04%Per cent of shares held by top holders
HolderShares% Held
Pzena Investment Management LLCas of 31 Dec 20253.99m9.52%
BlackRock Fund Advisorsas of 31 Dec 20253.22m7.68%
Allspring Global Investments LLCas of 31 Dec 20252.66m6.34%
The Vanguard Group, Inc.as of 31 Dec 20252.63m6.28%
Dimensional Fund Advisors LPas of 31 Dec 20251.68m4.01%
Cooke & Bieler LPas of 31 Dec 20251.63m3.89%
Neuberger Berman Investment Advisers LLCas of 31 Dec 20251.49m3.54%
Frontier Capital Management Co. LLCas of 30 Sep 20251.32m3.14%
LSV Asset Managementas of 31 Dec 20251.24m2.97%
D. E. Shaw & Co. LPas of 30 Sep 20251.12m2.67%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.